PD-1/PD-L1 Immune Checkpoint Inhibitors for Unresectable Locally Advanced or Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
PD-1/PD-L1 immune checkpoint inhibitors in the treatment of unresectable locally advanced or metastatic triple negative breast cancer: a meta-analysis on their efficacy and safety
BMC Cancer 2024 Oct 31;24(1)1339, Z Wang, P You, Z Yang, H Xiao, X Tang, Y Pan, X Li, F GaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.